ISIS Pharmaceuticals founder, chairman & CEO Stanley Crooke, offers insight on the status of his company's drug Kynamro, and the competition in the pharmaceutical industry.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT